Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-FR Version v14-FR
Language French French
Date Updated 2022-04-07 2022-02-22
Drug Identification Number 02490773 02490773
Brand name ERTAPENEM FOR INJECTION ERTAPENEM FOR INJECTION
Common or Proper name ERTAPENEM for Injection ERTAPENEM for Injection
Company Name JUNO PHARMACEUTICALS CORP. JUNO PHARMACEUTICALS CORP.
Ingredients ERTAPENEM ERTAPENEM
Strength(s) 1G 1G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 10 x 1g vial (Carton) 10 x 1g vial (Carton)
ATC code J01DH J01DH
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2021-08-31 2021-08-31
Actual start date
Estimated end date 2022-03-31 2022-03-31
Actual end date 2022-03-31
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments due to COVID disruptions there have been delays on this product due to COVID disruptions there have been delays on this product
Health Canada comments